| 04/29/2026 3:05 PM | Indaptus Therapeutics (1857044) Subject Yao Yun (2120637) Filed by | Form SCHEDULE 13D/A | |
| 04/24/2026 4:00 PM | Indaptus Therapeutics (1857044) Filer | Form 8-K/A | |
| 04/22/2026 8:59 PM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/20/2026 3:05 PM | Indaptus Therapeutics (1857044) Issuer Lu Qinglai (2127285) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/06/2026 3:40 PM | Indaptus Therapeutics (1857044) Subject YA II PN, Ltd. (1463928) Filed by | Form SCHEDULE 13G/A | |
| 04/03/2026 11:00 AM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/02/2026 6:15 PM | Dai Junyi (2022463) Reporting Indaptus Therapeutics (1857044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/02/2026 6:16 PM | Indaptus Therapeutics (1857044) Issuer SINO LION VENTURES Ltd (2120638) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/02/2026 6:18 PM | Indaptus Therapeutics (1857044) Issuer Yao Yun (2120637) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/30/2026 8:46 PM | Indaptus Therapeutics (1857044) Subject Yao Yun (2120637) Filed by | Form SCHEDULE 13D | |
| 03/24/2026 3:30 PM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for INDP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Indaptus Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/24/2026 3:02 PM | Indaptus Therapeutics (1857044) Issuer Lazar David E. (1932843) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 4:20 PM | Indaptus Therapeutics (1857044) Subject Lazar David E. (1932843) Filed by | Form SCHEDULE 13D | |
| 02/12/2026 8:30 AM | Indaptus Therapeutics (1857044) Filer | Form DEFA14A | |
| 02/12/2026 8:30 AM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/22/2026 8:56 PM | Indaptus Therapeutics (1857044) Issuer NATAN DAVID (1253108) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:57 PM | Ben-Tzvi Avraham (1944721) Reporting Indaptus Therapeutics (1857044) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 4:21 PM | Indaptus Therapeutics (1857044) Filer | Form DEF 14A | |
| 01/20/2026 3:06 PM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 3:05 PM | Indaptus Therapeutics (1857044) Issuer NATAN DAVID (1253108) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/08/2026 4:26 PM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/08/2026 4:22 PM | Indaptus Therapeutics (1857044) Filer | Form PRE 14A | |
| 01/02/2026 3:05 PM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/23/2025 6:06 PM | Ben-Tzvi Avraham (1944721) Reporting Indaptus Therapeutics (1857044) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 12/23/2025 6:06 PM | Indaptus Therapeutics (1857044) Issuer Lazar David E. (1932843) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 12/23/2025 4:22 PM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2025 7:30 AM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2025 7:31 AM | Indaptus Therapeutics (1857044) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/04/2025 3:01 PM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/03/2025 12:27 PM | Indaptus Therapeutics (1857044) Filer | Form S-1/A | |
| 09/02/2025 8:14 AM | Indaptus Therapeutics (1857044) Filer | Form 424B5 | |
| 09/02/2025 8:15 AM | Indaptus Therapeutics (1857044) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 08/20/2025 11:15 PM | Indaptus Therapeutics (1857044) Filer | Form EFFECT | |
| 08/20/2025 11:15 PM | Indaptus Therapeutics (1857044) Filer | Form EFFECT | |
| 08/13/2025 7:00 AM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2025 7:01 AM | Indaptus Therapeutics (1857044) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/29/2025 3:15 PM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/29/2025 3:15 PM | Indaptus Therapeutics (1857044) Issuer Meckler Jeffrey A (1506916) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/16/2025 3:15 PM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/01/2025 7:38 AM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/26/2025 4:15 PM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
| 06/23/2025 3:37 PM | Indaptus Therapeutics (1857044) Filer | Form DEF 14A | |
| 06/13/2025 8:48 AM | Indaptus Therapeutics (1857044) Filer | Form PRE 14A | |
| 06/13/2025 7:15 AM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/14/2025 7:00 AM | Indaptus Therapeutics (1857044) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/14/2025 7:01 AM | Indaptus Therapeutics (1857044) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |